Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
The metabolic syndrome: A high-risk state for cancer?.

The American journal of pathology

Cowey S, Hardy RW.
PMID: 17071576
Am J Pathol. 2006 Nov;169(5):1505-22. doi: 10.2353/ajpath.2006.051090.

The metabolic syndrome is composed of cardiovascular risk factors including increased body mass index/waist circumference, blood pressure, plasma glucose, and triglycerides, as well as decreased high-density lipoprotein cholesterol. The essence of the metabolic syndrome lies in the clustering of...

Cite
Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol. 2006;169(5):1505-22doi: 10.2353/ajpath.2006.051090.
Cowey, S., & Hardy, R. W. (2006). The metabolic syndrome: A high-risk state for cancer?. The American journal of pathology, 169(5), 1505-22. https://doi.org/10.2353/ajpath.2006.051090
Cowey, Stephanie, and Hardy, Robert W. "The metabolic syndrome: A high-risk state for cancer?." The American journal of pathology vol. 169,5 (2006): 1505-22. doi: https://doi.org/10.2353/ajpath.2006.051090
Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol. 2006 Nov;169(5):1505-22. doi: 10.2353/ajpath.2006.051090. PMID: 17071576; PMCID: PMC1780220.
Copy Download .nbib Format: NLM
Exploring disease through metabolomics.

ACS chemical biology

Vinayavekhin N, Homan EA, Saghatelian A.
PMID: 20020774
ACS Chem Biol. 2010 Jan 15;5(1):91-103. doi: 10.1021/cb900271r.

Metabolomics approaches provide an analysis of changing metabolite levels in biological samples. In the past decade, technical advances have spurred the application of metabolomics in a variety of diverse research areas spanning basic, biomedical, and clinical sciences. In particular,...

Cite
Vinayavekhin N, Homan EA, Saghatelian A. Exploring disease through metabolomics. ACS Chem Biol. 2010;5(1):91-103doi: 10.1021/cb900271r.
Vinayavekhin, N., Homan, E. A., & Saghatelian, A. (2010). Exploring disease through metabolomics. ACS chemical biology, 5(1), 91-103. https://doi.org/10.1021/cb900271r
Vinayavekhin, Nawaporn, et al. "Exploring disease through metabolomics." ACS chemical biology vol. 5,1 (2010): 91-103. doi: https://doi.org/10.1021/cb900271r
Vinayavekhin N, Homan EA, Saghatelian A. Exploring disease through metabolomics. ACS Chem Biol. 2010 Jan 15;5(1):91-103. doi: 10.1021/cb900271r. PMID: 20020774.
Copy Download .nbib Format: NLM
Metabolic syndrome and future risk of diabetes.

Diabetic medicine : a journal of the British Diabetic Association

Hitman GA.
PMID: 21749440
Diabet Med. 2011 Aug;28(8):883. doi: 10.1111/j.1464-5491.2011.03369.x.

No abstract available.

Cite
Hitman GA. Metabolic syndrome and future risk of diabetes. Diabet Med. 2011;28(8):883doi: 10.1111/j.1464-5491.2011.03369.x.
Hitman, G. A. (2011). Metabolic syndrome and future risk of diabetes. Diabetic medicine : a journal of the British Diabetic Association, 28(8), 883. https://doi.org/10.1111/j.1464-5491.2011.03369.x
Hitman, G A. "Metabolic syndrome and future risk of diabetes." Diabetic medicine : a journal of the British Diabetic Association vol. 28,8 (2011): 883. doi: https://doi.org/10.1111/j.1464-5491.2011.03369.x
Hitman GA. Metabolic syndrome and future risk of diabetes. Diabet Med. 2011 Aug;28(8):883. doi: 10.1111/j.1464-5491.2011.03369.x. PMID: 21749440.
Copy Download .nbib Format: NLM
Metabolic syndrome and chronic kidney disease.

Current opinion in nephrology and hypertension

Singh AK, Kari JA.
PMID: 23340215
Curr Opin Nephrol Hypertens. 2013 Mar;22(2):198-203. doi: 10.1097/MNH.0b013e32835dda78.

PURPOSE OF REVIEW: The association of the metabolic syndrome (MetS) with cardiovascular risk, mortality, type 2 diabetes mellitus, stroke, nonfatty liver disease and gout is well known. However, the association of the MetS with chronic kidney disease (CKD) is...

Cite
Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens. 2013;22(2):198-203doi: 10.1097/MNH.0b013e32835dda78.
Singh, A. K., & Kari, J. A. (2013). Metabolic syndrome and chronic kidney disease. Current opinion in nephrology and hypertension, 22(2), 198-203. https://doi.org/10.1097/MNH.0b013e32835dda78
Singh, Ajay K, and Kari, Jameela A. "Metabolic syndrome and chronic kidney disease." Current opinion in nephrology and hypertension vol. 22,2 (2013): 198-203. doi: https://doi.org/10.1097/MNH.0b013e32835dda78
Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens. 2013 Mar;22(2):198-203. doi: 10.1097/MNH.0b013e32835dda78. PMID: 23340215.
Copy Download .nbib Format: NLM
The association between glycemic index, glycemic load, and metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies.

European journal of nutrition

Zhang JY, Jiang YT, Liu YS, Chang Q, Zhao YH, Wu QJ.
PMID: 31680212
Eur J Nutr. 2020 Mar;59(2):451-463. doi: 10.1007/s00394-019-02124-z. Epub 2019 Nov 03.

PURPOSE: The association of glycemic index (GI) and glycemic load (GL) with metabolic syndrome (MetS) is controversial. Therefore, we conducted this first systematic review and dose-response meta-analysis of observational studies to quantify these associations.METHODS: We searched PubMed, EMBASE, Web...

Cite
Zhang JY, Jiang YT, Liu YS, et al. The association between glycemic index, glycemic load, and metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies. Eur J Nutr. 2019;59(2):451-463doi: 10.1007/s00394-019-02124-z.
Zhang, J. Y., Jiang, Y. T., Liu, Y. S., Chang, Q., Zhao, Y. H., & Wu, Q. J. (2020). The association between glycemic index, glycemic load, and metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies. European journal of nutrition, 59(2), 451-463. https://doi.org/10.1007/s00394-019-02124-z
Zhang, Jia-Yu, et al. "The association between glycemic index, glycemic load, and metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies." European journal of nutrition vol. 59,2 (2020): 451-463. doi: https://doi.org/10.1007/s00394-019-02124-z
Zhang JY, Jiang YT, Liu YS, Chang Q, Zhao YH, Wu QJ. The association between glycemic index, glycemic load, and metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies. Eur J Nutr. 2020 Mar;59(2):451-463. doi: 10.1007/s00394-019-02124-z. Epub 2019 Nov 03. PMID: 31680212.
Copy Download .nbib Format: NLM
Metabolic syndrome: why the controversy?.

Current diabetes reports

Pratley RE.
PMID: 17348123
Curr Diab Rep. 2007 Feb;7(1):56-9. doi: 10.1007/s11892-007-0010-x.

As originally conceived, the metabolic syndrome defined a clustering of cardiovascular disease risk factors with insulin resistance as the common, underlying pathophysiologic determinant. The definition of the syndrome has evolved since then, with several groups proposing somewhat differing definitions....

Cite
Pratley RE. Metabolic syndrome: why the controversy?. Curr Diab Rep. 2007;7(1):56-9doi: 10.1007/s11892-007-0010-x.
Pratley, R. E. (2007). Metabolic syndrome: why the controversy?. Current diabetes reports, 7(1), 56-9. https://doi.org/10.1007/s11892-007-0010-x
Pratley, Richard E. "Metabolic syndrome: why the controversy?." Current diabetes reports vol. 7,1 (2007): 56-9. doi: https://doi.org/10.1007/s11892-007-0010-x
Pratley RE. Metabolic syndrome: why the controversy?. Curr Diab Rep. 2007 Feb;7(1):56-9. doi: 10.1007/s11892-007-0010-x. PMID: 17348123.
Copy Download .nbib Format: NLM
[Evolution of metabolic syndrome].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Zvenigorodskaia LA, Konev IuV, Efremov LI.
PMID: 21033076
Eksp Klin Gastroenterol. 2010;(7):3-5.

No abstract available.

Cite
Zvenigorodskaia LA, Konev IuV, Efremov LI. [Evolution of metabolic syndrome]. Eksp Klin Gastroenterol. 2010;(7):3-5
Zvenigorodskaia, L. A., Konev, I. u. V., & Efremov, L. I. (2010). [Evolution of metabolic syndrome]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, (7), 3-5.
Zvenigorodskaia, L A, et al. "[Evolution of metabolic syndrome]." Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology vol. ,7 (2010): 3-5.
Zvenigorodskaia LA, Konev IuV, Efremov LI. [Evolution of metabolic syndrome]. Eksp Klin Gastroenterol. 2010;(7):3-5. Russian. PMID: 21033076.
Copy Download .nbib Format: NLM
Comment on Steinberg et al: Reducing Metabolic Syndrome Risk Using a Personalized Wellness Program.

Journal of occupational and environmental medicine

Mattke S.
PMID: 26949888
J Occup Environ Med. 2016 Mar;58(3):e114. doi: 10.1097/JOM.0000000000000658.

No abstract available.

Cite
Mattke S. Comment on Steinberg et al: Reducing Metabolic Syndrome Risk Using a Personalized Wellness Program. J Occup Environ Med. 2016;58(3):e114doi: 10.1097/JOM.0000000000000658.
Mattke, S. (2016). Comment on Steinberg et al: Reducing Metabolic Syndrome Risk Using a Personalized Wellness Program. Journal of occupational and environmental medicine, 58(3), e114. https://doi.org/10.1097/JOM.0000000000000658
Mattke, Soeren. "Comment on Steinberg et al: Reducing Metabolic Syndrome Risk Using a Personalized Wellness Program." Journal of occupational and environmental medicine vol. 58,3 (2016): e114. doi: https://doi.org/10.1097/JOM.0000000000000658
Mattke S. Comment on Steinberg et al: Reducing Metabolic Syndrome Risk Using a Personalized Wellness Program. J Occup Environ Med. 2016 Mar;58(3):e114. doi: 10.1097/JOM.0000000000000658. PMID: 26949888.
Copy Download .nbib Format: NLM
Epigenetic manifestation of metabolic syndrome and dietary management.

Antioxidants & redox signaling

Chaudhary N, Nakka KK, Maulik N, Chattopadhyay S.
PMID: 22229755
Antioxid Redox Signal. 2012 Jul 15;17(2):254-81. doi: 10.1089/ars.2011.4387. Epub 2012 Mar 02.

SIGNIFICANCE: Metabolic syndrome constitutes a group of disorders such as insulin resistance, hypertension, and hypertriglyceridemia, predisposing an individual to risk factors such as cardiovascular disease, diabetes, obesity, and dyslipidemia. A majority of these diseases are influenced by the environmental...

Cite
Chaudhary N, Nakka KK, Maulik N, et al. Epigenetic manifestation of metabolic syndrome and dietary management. Antioxid Redox Signal. 2012;17(2):254-81doi: 10.1089/ars.2011.4387.
Chaudhary, N., Nakka, K. K., Maulik, N., & Chattopadhyay, S. (2012). Epigenetic manifestation of metabolic syndrome and dietary management. Antioxidants & redox signaling, 17(2), 254-81. https://doi.org/10.1089/ars.2011.4387
Chaudhary, Nidhi, et al. "Epigenetic manifestation of metabolic syndrome and dietary management." Antioxidants & redox signaling vol. 17,2 (2012): 254-81. doi: https://doi.org/10.1089/ars.2011.4387
Chaudhary N, Nakka KK, Maulik N, Chattopadhyay S. Epigenetic manifestation of metabolic syndrome and dietary management. Antioxid Redox Signal. 2012 Jul 15;17(2):254-81. doi: 10.1089/ars.2011.4387. Epub 2012 Mar 02. PMID: 22229755.
Copy Download .nbib Format: NLM
Metabolic syndrome predicts plaque rupture in patients with acute myocardial infarction. An optical coherence study.

International journal of cardiology

Synetos A, Papanikolaou A, Toutouzas K, Georgiopoulos G, Karanasos A, Drakopoulou M, Latsios G, Papaioannou S, Tsiamis E, Tousoulis D.
PMID: 26889600
Int J Cardiol. 2016 Apr 15;209:139-41. doi: 10.1016/j.ijcard.2016.02.006. Epub 2016 Feb 02.

No abstract available.

Cite
Synetos A, Papanikolaou A, Toutouzas K, et al. Metabolic syndrome predicts plaque rupture in patients with acute myocardial infarction. An optical coherence study. Int J Cardiol. 2016;209:139-41doi: 10.1016/j.ijcard.2016.02.006.
Synetos, A., Papanikolaou, A., Toutouzas, K., Georgiopoulos, G., Karanasos, A., Drakopoulou, M., Latsios, G., Papaioannou, S., Tsiamis, E., & Tousoulis, D. (2016). Metabolic syndrome predicts plaque rupture in patients with acute myocardial infarction. An optical coherence study. International journal of cardiology, 209139-41. https://doi.org/10.1016/j.ijcard.2016.02.006
Synetos, Andreas, et al. "Metabolic syndrome predicts plaque rupture in patients with acute myocardial infarction. An optical coherence study." International journal of cardiology vol. 209 (2016): 139-41. doi: https://doi.org/10.1016/j.ijcard.2016.02.006
Synetos A, Papanikolaou A, Toutouzas K, Georgiopoulos G, Karanasos A, Drakopoulou M, Latsios G, Papaioannou S, Tsiamis E, Tousoulis D. Metabolic syndrome predicts plaque rupture in patients with acute myocardial infarction. An optical coherence study. Int J Cardiol. 2016 Apr 15;209:139-41. doi: 10.1016/j.ijcard.2016.02.006. Epub 2016 Feb 02. PMID: 26889600.
Copy Download .nbib Format: NLM
Cardiometabolic crosstalk in obesity-associated arterial hypertension.

Reviews in endocrine & metabolic disorders

Jordan J, Birkenfeld AL.
PMID: 26961160
Rev Endocr Metab Disord. 2016 Mar;17(1):19-28. doi: 10.1007/s11154-016-9348-1.

Abdominal obesity and elevated blood pressure commonly occur in the same patient and are key components of the metabolic syndrome. However, the association between obesity and increased blood pressure is variable. We review mechanisms linking cardiovascular and metabolic disease...

Cite
Jordan J, Birkenfeld AL. Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord. 2016;17(1):19-28doi: 10.1007/s11154-016-9348-1.
Jordan, J., & Birkenfeld, A. L. (2016). Cardiometabolic crosstalk in obesity-associated arterial hypertension. Reviews in endocrine & metabolic disorders, 17(1), 19-28. https://doi.org/10.1007/s11154-016-9348-1
Jordan, Jens, and Birkenfeld, Andreas L. "Cardiometabolic crosstalk in obesity-associated arterial hypertension." Reviews in endocrine & metabolic disorders vol. 17,1 (2016): 19-28. doi: https://doi.org/10.1007/s11154-016-9348-1
Jordan J, Birkenfeld AL. Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord. 2016 Mar;17(1):19-28. doi: 10.1007/s11154-016-9348-1. PMID: 26961160.
Copy Download .nbib Format: NLM
Exercise in a bottle: Elucidating how exercise conveys health benefits might lead to new therapeutic options for a range of diseases from cancer to metabolic syndrome.

EMBO reports

Hunter P.
PMID: 26747280
EMBO Rep. 2016 Feb;17(2):136-8. doi: 10.15252/embr.201541835. Epub 2016 Jan 08.

No abstract available.

Cite
Hunter P. Exercise in a bottle: Elucidating how exercise conveys health benefits might lead to new therapeutic options for a range of diseases from cancer to metabolic syndrome. EMBO Rep. 2016;17(2):136-8doi: 10.15252/embr.201541835.
Hunter, P. (2016). Exercise in a bottle: Elucidating how exercise conveys health benefits might lead to new therapeutic options for a range of diseases from cancer to metabolic syndrome. EMBO reports, 17(2), 136-8. https://doi.org/10.15252/embr.201541835
Hunter, Philip. "Exercise in a bottle: Elucidating how exercise conveys health benefits might lead to new therapeutic options for a range of diseases from cancer to metabolic syndrome." EMBO reports vol. 17,2 (2016): 136-8. doi: https://doi.org/10.15252/embr.201541835
Hunter P. Exercise in a bottle: Elucidating how exercise conveys health benefits might lead to new therapeutic options for a range of diseases from cancer to metabolic syndrome. EMBO Rep. 2016 Feb;17(2):136-8. doi: 10.15252/embr.201541835. Epub 2016 Jan 08. PMID: 26747280; PMCID: PMC5290811.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries